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Effects of grape seed extract on oxidative stress and antioxidant defense
markers in streptozotocin-induced diabetic rats
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Background/aim: To evaluate the effects of grape seed extract (GSE) supplementation on oxidative stress and antioxidant markers in
streptozotocin (STZ)-induced diabetic rats.
Materials and methods: Thirty-six male rats were divided into the following four groups: control, GSE-supplemented control, diabetic,
and GSE-supplemented diabetic. Beginning on day 7 after STZ injection, the rats were administered GSE (100 mg kg–1 day–1) in drinking
water for 6 weeks. At the end of week 6, rats were sacrificed by cardiac puncture. Plasma nitric oxide (NO) levels and xanthine oxidase
(XO), adenosine deaminase (ADA), and glutathione peroxidase (GPx) activities were analyzed.
Results: Both XO and ADA activities increased and NO levels decreased in diabetic rats (P < 0.05). GSE supplementation normalized
all of these changes. Antioxidant enzyme activities decreased in diabetic rats compared to the controls (P < 0.05). GSE supplementation
increased antioxidant enzyme activities in both diabetic and healthy rats (P < 0.05).
Conclusion: These findings suggest that 6 weeks of oral GSE supplementation may prevent oxidative stress and improve antioxidant
status in diabetic rats.
Key words: Experimental diabetes, grape seed extract, oxidative stress, antioxidant enzyme activity, adenosine deaminase, nitric oxide

1. Introduction
The function of oxidative stress in diabetes has been
widely discussed since the early 1980s (1). Oxidative
stress causes abnormalities in insulin secretion (2) and
is involved in the maturation and progression of diabetes
and its complications (3,4). Advanced oxidative stress
in diabetes is due to multiple factors, such as glucose
autoxidation. Other factors, such as cellular oxidation/
reduction imbalances, reduction in antioxidant systems,
and polyol pathways, also play a role (5). Hyperglycemia
engenders free radicals and also impairs the endogenous
antioxidant defense system in many ways during diabetes
(4). To protect cells against damage caused by reactive
oxygen species (ROS), organisms have developed several
defense mechanisms. These include antioxidant enzymes
such as superoxide dismutase, glutathione peroxidase,
and catalase and different antioxidant molecules including
glutathione, flavonoids, vitamin A, vitamin E, vitamin C,
and ubiquinone (6).
Grape seed contains polyphenol members of the family
of proanthocyanidins (7). Proanthocyanidins are widely
present in vegetables, fruits, seeds, nuts, flowers, and
* Correspondence: mbelviranli@yahoo.com

especially grape seed. The pharmacological, biological,
and medicinal properties of proanthocyanidins have
been widely reviewed (7‒9). In addition to antioxidant
activity,
proanthocyanidins
display
vasodilatory,
antiallergic, anticarcinogenic, antiinflammatory, antiviral,
cardioprotective, immune-stimulating, and estrogenic
activities, as well as being inhibitors of enzymes such as
cyclooxygenase, phospholipase A2, and lipoxygenase
(7,10). It has been discovered that grape seed extract
(GSE) provides greater protection against free radicals and
free radical-induced lipid peroxidation and DNA damage
than vitamin E, vitamin C, and β-carotene (11).
There are limited studies (12‒14) investigating the
effects of GSE supplementation on diabetes-induced
oxidative stress in rats. However, no study to date has
investigated the effects of long-term GSE supplementation
on oxidative stress and antioxidant defense systems in
diabetic conditions in humans and experimental animals.
Therefore, the aim of this study was to investigate the
effects of GSE supplementation of 6 weeks in duration
on oxidative stress and activities of circulatory enzymatic
antioxidants in streptozotocin-induced diabetic rats.
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2. Materials and methods
2.1. Chemicals
Streptozotocin (STZ) was obtained from Sigma-Aldrich
(USA). All other chemicals were purchased from Merck
(Germany).
GSE (ActiVin) was kindly donated by San Joaquin
Valley Concentrates (USA). GSE was extracted with
a standardized water-ethanol mixture. GSE contains
monomeric (less than 5%), dimeric (54%), trimeric
(13%), and tetrameric proanthocyanidins (7%) and other
flavonoids. Antioxidants like catechins also exist in the
extract (15‒17).
2.2. Animals
The study protocol was approved by the Ethics Committee
of Experimental Medicine Research and Application
Center, Selçuk University. The principles of laboratory
animal care outlined in the National Institutes of Health
guideline were followed in all these experiments. Thirty-six
adult male Sprague Dawley rats (aged 16 weeks) weighing
200‒300 g (236.1 ± 23.8 g) were used in the study. All
animals were housed individually in polycarbonate cages
(Tecniplast, Italy) with a 12-h light/dark cycle at 21 ± 2
°C and 50% humidity. The animals were given Purina rat
chow and tap water ad libitum.
2.3. Induction of experimental diabetes
A total of 36 rats were divided into two main groups:
nondiabetic (n = 19) and diabetic (n = 17). Diabetes was
induced by a single intraperitoneal (i.p.) injection of STZ
at a dose of 50 mg/kg body weight, freshly dissolved in
physiological saline. It has been demonstrated that STZ
destroys pancreatic beta cells and is a model of type 1
diabetes (18). Seven days after i.p. administration of STZ,
diabetes was confirmed by measuring blood glucose levels
with a glucometer (Optium Plus, Abbott Diabetes Care,
UK) in the blood samples taken from tail. Rats with a blood
glucose level of 300 mg/dL or higher were considered to be
diabetic. Diabetes was observed in 13 of the 17 rats.
2.4. Groups and supplementation procedure
Rats were divided into four groups as follows:
Control (C, n = 9): Tap water was given ad libitum
during the study period.
GSE-supplemented control (GC, n = 10): GSE was
given in drinking water at 100 mg kg–1 day–1 for 6 weeks.
Diabetic (D, n = 6): Tap water was given ad libitum
during the study period.
GSE-supplemented diabetic (GD, n = 7): After the
induction of diabetes was confirmed, GSE was given in
drinking water at 100 mg kg–1 day–1 for 6 weeks.
GSE supplementation started 7 days after STZ-injection
and this was considered the first day of supplementation.
The 100 mg kg–1 dosage was chosen because previous
studies (13,19) demonstrated antioxidant effects of this
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dosage in rats. Daily water consumption of rats was
approximately 10‒12 mL 100 g body weight–1 (20). GSE
was dissolved in a volume of tap water less than the rats’
daily volume consumption. First, rats were given tap water
containing GSE, and then water bottles were filled with
tap water again. Therefore, rats were given tap water ad
libitum and this procedure was repeated every day during
the 6 weeks. Changes in body weight were recorded at the
end of the experiment.
At the end of week 6, blood samples for the analysis
were drawn by cardiac puncture under anesthesia and
then rats were sacrificed by cervical dislocation.
2.5. Biochemical analysis
Blood samples taken from the rats were transferred into
EDTA-containing tubes and centrifuged at 1000 × g for 10
min at 4 °C. Plasma samples were aliquoted and stored at
‒80 °C until biochemical analysis.
Plasma xanthine oxidase (XO) activity was measured
spectrophotometrically according to the method of Prajda
and Weber (21). This assay measures the formation of uric
acid from xanthine through the increase in absorbance at
293 nm. Plasma XO activity was expressed as U mL–1.
Plasma adenosine deaminase (ADA) activity was
estimated spectrophotometrically according to the method
of Giusti (22), which is based on the direct measurement
of the formation of ammonia, produced when ADA acts in
excess of adenosine. Plasma ADA activity was expressed
as U L–1.
Nitric oxide (NO) is quickly oxidized to nitrite
(NO2−) and nitrate (NO3−), respectively. The analysis of
plasma nitrite and nitrate levels was based on the Griess
reaction (23). Total nitrite (NO2− + NO3−) was measured
by spectrophotometer at 545 nm. Plasma NO level was
expressed as mmol L–1.
Plasma glutathione peroxidase (GPx) activity was
measured using a kinetic colorimetric assay from Cayman
Chemical Company (USA). The assay kit measures GPx
activity by a coupled reaction with glutathione reductase.
The decrease rate of the absorbance of NADPH at 340 nm
is proportional to GPx activity. GPx activity was expressed
as nmol min–1 mL–1.
2.6. Statistical analysis
Statistical analysis was performed using SPSS 15.0 (SPSS
Inc., USA). Data were expressed as mean ± SD. Statistical
significance of differences among the groups was calculated
by one-way analysis of variance (ANOVA) and post hoc
Tukey test. P < 0.05 was considered statistically significant.
3. Results
Body weight changes of the groups are shown in Figure
1. At the end of the study, although body weight of the
control groups increased (+35.6 ± 21.1 and +45.2 ± 9.3 g in
C and GC, respectively), diabetic groups presented weight
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Figure 1. Body weight changes of the groups. C: Control, GC:
GSE-supplemented control, D: diabetic, GD: GSE-supplemented
diabetic. aP < 0.05 compared to C, bP < 0.05 compared to GC.

loss compared to both controls (–29.3 ± 22.3 and –18.3 ±
26.9 g in D and GD, respectively) (P < 0.05). There was no
difference in mean weight loss between diabetic and GSEsupplemented diabetic groups. Blood glucose levels of the
rats are shown in the Table. GSE supplementation did not
affect blood glucose levels in diabetic rats (P > 0.05).

Both XO and ADA activities in diabetic rats were
higher than those of the other groups (P < 0.05). There
were no significant differences among the C, GC, and GD
groups: XO activities were 0.22 ± 0.07, 0.18 ± 0.04, 0.39
± 0.06, and 0.23 ± 0.06 in the C, GC, D, and GD groups,
respectively, and ADA activities were 14.17 ± 2.25, 15.18 ±
4.31, 27.55 ± 2.92, and 17.37 ± 4.41 in the C, GC, D, and
GD groups, respectively (Figures 2 and 3, respectively).
Plasma NO levels increased in the GC group compared
to the control and they were the highest in this group
(P < 0.05). Plasma NO levels decreased in diabetic rats
compared to the GC group (P < 0.05), but there was no
difference between the control and diabetic group. NO
levels in the GD groups were higher than those of the
diabetic group (P < 0.05) but were not different from those
of the control and GC groups (NO levels were 75.00 ± 8.71,
94.22 ± 7.77, 65.60 ± 3.40, and 84.10 ± 8.35 in the C, GC,
D, and GD groups, respectively) (Figure 4).
GPx activities increased in the GC group compared
to the control (P < 0.05). Antioxidant enzyme activities
significantly decreased in diabetic groups compared
to the controls, and GSE supplementation ameliorated
this decrease in antioxidant enzyme activities (P < 0.05)
(GPx activities were 99.19 ± 7.28, 110.32 ± 3.43, 82.84 ±
5.40, and 94.98 ± 2.99 in the C, GC, D, and GD groups,
respectively) (Figure 5).

Table. Blood glucose levels of the diabetic groups before and after GSE supplementation.
Groups

n

Before supplementation (mg/dL)

After supplementation (mg/dL)

D

6

380.7 ± 38.7

464.3 ± 31.3

GD

7

385.6 ± 63.5

467.0 ± 36.5

D: Diabetic, GD: GSE-supplemented diabetic.
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Figure 2. Effect of GSE supplementation on plasma XO activities.
C: Control, GC: GSE-supplemented control, D: diabetic, GD:
GSE-supplemented diabetic. aP < 0.05 compared to C, bP < 0.05
compared to GC, dP < 0.05 compared to GD.
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Figure 3. Effect of GSE supplementation on plasma ADA
activities. C: Control, GC: GSE-supplemented control, D:
diabetic, GD: GSE-supplemented diabetic. aP < 0.05 compared to
C, bP < 0.05 compared to GC, dP < 0.05 compared to GD.
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Figure 4. Effect of GSE supplementation on plasma NO levels.
C: Control, GC: GSE-supplemented control, D: diabetic, GD:
GSE-supplemented diabetic. aP < 0.05 compared to C, bP < 0.05
compared to GC, cP < 0.05 compared to D.

Figure 5. Effect of GSE supplementation on plasma GPx activities.
C: Control, GC: GSE-supplemented control, D: diabetic, GD:
GSE-supplemented diabetic. aP < 0.05 compared to C, bP < 0.05
compared to GC, cP < 0.05 compared to D.

4. Discussion
Diabetes is usually accompanied by excessive production
of free radicals (3), and it was shown that hyperglycemiainduced ROS production could be a key event in the
expansion of diabetic complications (24). The sensitivity
of β-cells to oxidative stress has been attributed to their
low levels of antioxidants (25).
Our results demonstrated that body weight decreased
in diabetic rats during the 6-week experimental period.
These results suggest that these animals suffered growth
retardation due to the hindrance of glucose uptake (26)
but oral GSE supplementation did not affect body weight
in diabetic rats. Although in recent studies (14,26,27) it has
been suggested that oral GSE supplementation increased
body weight changes in diabetic rats compared to the
untreated diabetic controls, in these studies the GSE dosage
was larger (250 mg kg–1 day–1) and the supplementation
period was longer (24 weeks) than in our study. According
to their results, previous authors assumed that GSE could
show an anti-nonenzymatic glycation effect, having a
correlation with body weight gain (26).
In the present study, we observed that 6 weeks of oral
GSE supplementation did not affect blood glucose levels
in diabetic rats. In contrast to other studies (13,26,28,29),
in this study, although it was not statistically significant,
blood glucose levels increased in both the D and GD groups
after supplementation. One possible explanation for this
situation is related to the STZ dosage and duration of blood
glucose measurement. In the present study, we confirmed
diabetes 7 days after STZ administration. Our findings
suggest that β-cell destruction continued during the study
period, and therefore blood glucose levels were elevated
at the end of the study independently from the effect of
GSE. It is generally accepted that GSE supplementation

decreases blood glucose levels in diabetic rats (13,26,28).
Procyanidins influence insulin effects by acting on specific
parts of the insulin-signaling transduction pathway in STZinduced diabetic rats (12). These researchers also claimed
that GSE was an antihyperglycemic agent with insulinmimetic properties by increasing glucose transporter-4 in
the membrane. El-Alfy et al. (13) demonstrated that grape
seed proanthocyanidins ameliorated pancreatic damage in
alloxan-induced diabetic rats. Similarly, Al-Awwadi et al.
(29) showed that red wine polyphenols had antidiabetic
activity in STZ-induced diabetic rats. A recent study
(28) showed that GSE supplementation decreased blood
glucose concentrations and HbA1c levels in diabetic db/
db mice. However, consistent with our findings, Zhang et
al. (30) demonstrated that GSE supplementation did not
influence blood glucose levels in mice; they claimed that
the renoprotective effects of GSE were independent of
antihyperglycemia. Therefore, we may also suggest that GSE
shows antioxidant effects independent of antihyperglycemia.
The differences between the results might be due to the
supplementation period or GSE dosage.
Various studies (29‒34) have shown that clinical and
experimental diabetes are associated with increased
formation of free radicals and with decreases in antioxidant
potential. In the present study, plasma XO activity
significantly increased in diabetic rats. Increased XO
activity is related to oxidative damage induced by diabetes
and its complications (35). Celik et al. (36) showed that
XO activity was significantly increased in the brain tissue
of STZ-induced diabetic rats and they suggested that an
important source of increased ROS in the STZ-induced
diabetic rat was XO. GSE supplementation decreased
diabetes-induced overproduction of XO in the plasma
of diabetic rats. This is the first study investigating the
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effects of GSE supplementation on plasma XO activities
in diabetic rats and these findings support the antioxidant
potential of GSE.
Increased ADA activity was demonstrated in both
blood and tissues of diabetic humans and animals
(37‒40). This increase in ADA activity could be due to
the altered insulin-related T lymphocyte function that
plays a central role in the immune response (39) or the
induction of activity and/or expression of ADA in the
damaged tissue (41). Recent studies (42,43) have shown
that GSE supplementation reduces the concentration
of free Ca2+ and elevated Ca2+-ATPase activity in sciatic
nerves of diabetic rats. In the present study, we found that
GSE supplementation suppressed ADA activities in the
plasma of the diabetic rats. ADA inhibition may exert a
dual protective role by facilitating purine salvage for ATP
synthesis and inhibiting lipid peroxidation.
NO can exert a variety of biological activities in various
physiological and pathological conditions. It can be either
proapoptotic or antiapoptotic, depending on the type of
cell, the location, the timing, and the amount produced
(44). It has been shown that NO levels increase in diabetic
conditions (37,45,46). However, in the present study,
plasma NO levels in the diabetic group did not differ from
the control. According to these findings, the mechanisms
of similar NO levels in diabetic rats and controls are
unclear and more research is needed. It has been shown
that GSE increases NO levels by activating the inducible
NOS (47,48). In the present study, GSE supplementation
significantly increased plasma NO levels in both
supplemented groups compared to their own controls;
there was no difference between the GSE-supplemented
groups. These findings support the beneficial effects of

GSE on NO levels. In a previous study (49) we showed that
GSE supplementation restores endothelial function and
reduces the risk of vascular disease in diabetic rats. This
might be related to the increased NO production induced
by GSE supplementation.
A relationship between diabetes and oxidative stress has
been confirmed together with reduced total antioxidant
defense (50). Such a prooxidant environment was
demonstrated in our study by the inhibition of the activity
of antioxidant enzyme GPx. Decreased GPx activities were
observed in the blood of diabetic patients (36,51,52) and in
blood and tissues of diabetic animals (53,54). In our study,
6 weeks of GSE supplementation improved GPx activity
in diabetic rats and our results are consistent with those of
previous studies (27). The free radical scavenging activity
of GSE could be a possible reason for this reversal effect of
antioxidant enzyme activities (8).
In conclusion, in the present study, although GSE
supplementation did not affect blood glucose levels, it
induced a decrease in oxidative stress markers. These data
suggest that GSE supplementation affects oxidative stress
markers rather than blood glucose levels and more detailed
histopathological and molecular research is needed to
clarify the real mechanism of action of GSE. Additionally,
6 weeks of oral GSE supplementation exerted a protective
effect on oxidative stress and antioxidant enzyme activities
in STZ-induced diabetic rats. However, more detailed
animal studies are needed to clarify the mechanism of
action of GSE along with investigations in human subjects
to support these data.
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